Cite

HARVARD Citation

    Lux, S. et al. (2019). The antinociceptive effect of resveratrol in bone cancer pain is inhibited by the Silent Information Regulator 1 inhibitor selisistat. Journal of pharmacy and pharmacology. pp. 816-825. [Online]. 
  
Back to record